Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-02-09 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO of Aurora Cannabis Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. The content is primarily an officer certification regarding the interim filings, internal controls, and disclosure controls. It does not contain the actual interim financial statements or substantive financial data but rather attests to their accuracy and completeness. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3778 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2023-02-09 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of Aurora Cannabis Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. The document is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, including disclosure controls and internal controls over financial reporting. It does not contain the actual interim financial statements or substantive financial data itself, but rather attests to their validity. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself.
2023-02-09 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Aurora Cannabis's financial and operational results for the fiscal second quarter ended December 31, 2022. It includes comprehensive financial data such as net revenue, adjusted EBITDA, SG&A expenses, net loss, balance sheet strength, cash use, and operational highlights. The presence of detailed quarterly financial figures, comparisons to prior quarters and years, and discussion of business segments and operational efficiency clearly indicate this is a quarterly financial report. Additionally, the document mentions a conference call to discuss these results, which is typical for quarterly earnings releases. The document length (15,000 characters) and the depth of financial data confirm it is not a brief earnings release summary but a full interim/quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q2 2023
2023-02-09 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the sale of a facility by Aurora Cannabis and providing an update on the company's balance sheet and expected profitability. It contains no detailed financial statements, comprehensive financial analysis, or substantive financial data typical of an Interim/Quarterly Report or Annual Report. It is not a transcript, audit report, or regulatory filing. The content focuses on a capital transaction and financial position update, which aligns with a Capital/Financing Update. The document length is about 5,785 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-01-04 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release dated December 5, 2022, announcing Aurora Cannabis's repurchase of approximately $103 million principal amount of convertible notes. It discusses the impact on the company's balance sheet and debt reduction, highlighting financial strategy and operational updates. There are no detailed financial statements, comprehensive financial performance data, or management discussion and analysis typically found in annual or interim reports. The document is focused on a specific capital transaction (debt repurchase) and its financial implications. It is not a full financial report but an update on financing activities. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (6605 characters) and content support this classification with high confidence.
2022-12-05 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter of consent from a legal firm regarding a Prospectus Supplement for a short form base shelf prospectus related to the issuance of common shares upon exercise of warrants. It references legal opinions and compliance with securities regulations. The content is focused on legal consent and opinions related to a financing document (Prospectus Supplement), not the financing update itself. The document length is short (1849 characters) and it is a letter rather than a report or announcement of financial results. This fits best under Regulatory Filings (RNS) as it is a compliance/legal filing related to a financing prospectus, not the actual Capital/Financing Update (CAP) or a Prospectus itself.
2022-11-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.